“…For example, type 1 latency is defined by the expression of EBNA1 and EBERs and is associated with Burkitt's lymphoma (1,7,36). Type 2 latency is defined by EBNA1, LMP1, LMP2, and EBER expression and is associated with nasopharyngeal carcinoma, Hodgkin's disease, and peripheral T-cell lymphoma (1,7,36). The type 3 latency pattern is characterized by the expression of EBNA1, EBNA2, EBNA3A, EBNA3B, EBNA3C, EBNA-LP, LMP1, LMP2, and EBERs and is associated with lymphoproliferative disease, X-linked lymphoproliferative disease, and infectious mononucleosis (1,36).…”